Europe Esoteric Testing Market Size & Share Analysis - Growth, Trends, and Forecasts (2025 - 2030)

The Europe Esoteric Testing Market Report is Segmented by Test Type (Endocrinology, Infectious Disease, Oncology, Neurology, Toxicology, and Other Test Types), Technology (Flow Cytometry, Chemiluminescence Immunoassay, Mass Spectrometry, Radio Immunoassay, and Other Technologies), and Geography (Germany, The United Kingdom, France, Italy, Spain, and Rest of Europe). The Report Offers the Value (USD) for all the Above Segments.

Europe Esoteric Testing Market Size

Europe Esoteric Testing Market Summary

Europe Esoteric Testing Market Analysis

The Europe Esoteric Testing Market size is estimated at USD 8.68 billion in 2025, and is expected to reach USD 14.77 billion by 2030, at a CAGR of 11.23% during the forecast period (2025-2030).

The European esoteric testing market is anticipated to grow with the rising burden of chronic diseases, rare diseases, and increasing research expenditure. The rising prevalence of chronic illnesses and uncommon ailments in Europe is spurring the need for specialized testing. The widespread occurrence of diseases such as cancer, infectious agents, and unusual genetic conditions calls for cutting-edge diagnostic techniques to enable precise and timely recognition, contributing to market growth.

The region has an increasing burden of several chronic and rare diseases that require esoteric testing to be diagnosed on time. For instance, as per the International Diabetes Federation (IDF), in February 2022, over 4.47 million adults were reported to have diabetes in the total adult population in Italy, which was equivalent to a prevalence rate of 9.9%. It was also stated that over 1.2 million children and adolescents aged 19 years or less were reported to have type-1 diabetes. Thus, the growing burden of type I and type II diabetes is expected to increase demand for diagnosis with esoteric testing, which is likely to support the growth of the market.

Similarly, according to the data updated by the Spanish Network of Cancer Registries (REDECAN) in January 2023, approximately 279,260 new cases of cancer were expected to occur in Spain by the end of 2023, out of which 42,721 new cases of colorectal cancer, 31,282 cases of lung cancer, and 21,694 cases of urinary bladder cancer. Thus, with the vast patient base of chronic patients, the demand for esoteric tests is expected to increase for the timely or early diagnosis of underlying diseases, boosting the market’s growth during the forecast period.

Furthermore, recent developments by service providers are expected to increase the availability of esoteric testing in the region, which is likely to boost the market’s growth. For instance, in April 2022, Minaris Medical obtained the European Union In Vitro Diagnostic Medical Devices Regulation certification for fecal occult blood test reagents. Similarly, in November 2023, Arup Laboratories achieved the Conformité Européenne (CE) certification for the single-site use of AAV5 DetectCDx, aligning with the European Union's In Vitro Diagnostic Medical Devices Regulation. Developed in collaboration with BioMarin Pharmaceutical Inc., AAV5 DetectCDx functions as a companion diagnostic, aiding in the identification of adult patients eligible for BioMarin's groundbreaking gene therapy for severe hemophilia A, valoctocogene roxaparvovec-rvox (ROCTAVIAN). Thus, the launch and approval of innovative esoteric tests in the market are expected to contribute to the market's growth during the forecast period.

Therefore, owing to the factors above, the market studied is anticipated to grow during the forecast period. However, the stringent regulatory scenario is likely to impede the market’s growth.

Europe Esoteric Testing Industry Overview

The European esoteric testing market is fragmented in nature due to the presence of several service providers operating regionally. The market players adopted several strategies, such as expansion, acquisition, and new product launches, to stay competitive in the market. The leading players operating in the market include Eurofins Scientific, Nordic Laboratories, Buhlmann Diagnostics Corp, ACM Global Laboratories, and Medical Laboratory Bremen.

Europe Esoteric Testing Market Leaders

  1. Eurofins Scientific

  2. Nordic Laboratories

  3. Buhlmann Diagnostics Corp

  4. ACM Global Laboratories

  5. Medical Laboratory Bremen

  6. *Disclaimer: Major Players sorted in no particular order
Europe Esoteric Testing Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Europe Esoteric Testing Market News

  • May 2024: Bruker Corporation completed its acquisition of ELITechGroup (ELITech) for a cash consideration of EUR 870 million (USD 938.50 million), excluding the sale of ELITech's clinical chemistry business. ELITech is a specialized, rapidly expanding, and highly profitable provider of systems and assays for molecular diagnostics (MDx), biomedical systems, specialty in vitro diagnostics (IVD), and microbiology.
  • March 2023: OGT, a Sysmex Group company, received IVDR certification from the European Union (EU) for eight CytoCell fluorescence in situ hybridization (FISH) probes, which are intended for the diagnosis of patient management in hematological cancers and prenatal conditions.

Europe Esoteric Testing Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Burden of Chronic Diseases and Rare Diseases
    • 4.2.2 Increasing Research Expenditure
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Framework
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Test Type
    • 5.1.1 Endocrinology
    • 5.1.2 Infectious Disease
    • 5.1.3 Oncology
    • 5.1.4 Neurology
    • 5.1.5 Toxicology
    • 5.1.6 Other Test Types
  • 5.2 By Technology
    • 5.2.1 Flow Cytometry
    • 5.2.2 Chemiluminescence Immunoassay
    • 5.2.3 Mass Spectrometry
    • 5.2.4 Radio Immunoassay
    • 5.2.5 Other Technologies
  • 5.3 By Geography
    • 5.3.1 Germany
    • 5.3.2 United Kingdom
    • 5.3.3 France
    • 5.3.4 Italy
    • 5.3.5 Spain
    • 5.3.6 Rest of Europe

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 ACM Global Laboratories
    • 6.1.2 Foundation Medicine
    • 6.1.3 Arup Laboratories
    • 6.1.4 Exact Sciences
    • 6.1.5 Miraca Holdings Inc.
    • 6.1.6 Myriad Genetics Inc.
    • 6.1.7 Nordic Laboratories
    • 6.1.8 OPKO Health Inc.
    • 6.1.9 Quest Diagnostics Inc.
    • 6.1.10 Eurofins Scientific
    • 6.1.11 Buhlmann Diagnostics Corp.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Subject to Availability **Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Europe Esoteric Testing Industry Segmentation

As per the scope of the report, esoteric testing is used to analyze and detect rare substances and molecules. The European esoteric testing market is segmented by test type, technology, and geography. By test type, the market is segmented into endocrinology, infectious disease, oncology, neurology, toxicology, and other test types. By technology, the market is segmented into flow cytometry, chemiluminescence immunoassay, mass spectrometry, radioimmunoassay, and other technologies. By geography, the market is segmented into Germany, the United Kingdom, France, Italy, Spain, and Rest of Europe. The report offers the value (USD) for all the above segments.

By Test Type Endocrinology
Infectious Disease
Oncology
Neurology
Toxicology
Other Test Types
By Technology Flow Cytometry
Chemiluminescence Immunoassay
Mass Spectrometry
Radio Immunoassay
Other Technologies
By Geography Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Need A Different Region or Segment?
Customize Now

Europe Esoteric Testing Market Research FAQs

How big is the Europe Esoteric Testing Market?

The Europe Esoteric Testing Market size is expected to reach USD 8.68 billion in 2025 and grow at a CAGR of 11.23% to reach USD 14.77 billion by 2030.

What is the current Europe Esoteric Testing Market size?

In 2025, the Europe Esoteric Testing Market size is expected to reach USD 8.68 billion.

Who are the key players in Europe Esoteric Testing Market?

Eurofins Scientific, Nordic Laboratories, Buhlmann Diagnostics Corp, ACM Global Laboratories and Medical Laboratory Bremen are the major companies operating in the Europe Esoteric Testing Market.

What years does this Europe Esoteric Testing Market cover, and what was the market size in 2024?

In 2024, the Europe Esoteric Testing Market size was estimated at USD 7.71 billion. The report covers the Europe Esoteric Testing Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Europe Esoteric Testing Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Europe Esoteric Testing Industry Report

Statistics for the 2025 Europe Esoteric Testing market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Europe Esoteric Testing analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Europe Esoteric Testing Market Report Snapshots

Compare market size and growth of Europe Esoteric Testing Market with other markets in Healthcare Industry

Europe Esoteric Testing Market Size & Share Analysis - Growth, Trends, and Forecasts (2025 - 2030)